Clinical Trial Update: Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating single-dose ketamine for acute pain and depression in the emergency department was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Maria Pacella | Conditions: Acute Pain, Depression | Phase 2, Phase 3 | Status: WITHDRAWN